(Q91990300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

review article

2 references

1 August 2020

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

1 reference

1 reference

1 reference

2 references

1 July 2020

1 August 2020

precursor B-cell lymphoblastic leukemia

2 references

1 July 2020

1 August 2020

RNA virus infectious disease

1 reference

1 July 2020

2 references

1 July 2020

1 August 2020

2 references

1 July 2020

1 August 2020

adoptive immunotherapy

1 reference

1 August 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

Bhagirathbhai R. Dholaria

26 April 2020

4

object named as

Bhagirathbhai Dholaria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

10

Loretta J Nastoupil

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

13

David L Porter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

5

Stephan A Grupp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

author name string

Veronika Bachanova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Michael R Bishop

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Parastoo Dahi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Brandon Hayes-Lattin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Richard T Maziarz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Joseph P McGuirk

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Olalekan O Oluwole

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Miguel-Angel Perales

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Peter A Riedell

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

CAR T Cell Consortium

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

publication date

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

Biology of Blood and Marrow Transplantation

26 April 2020

1 July 2020

2 references

1 July 2020

1 August 2020

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 July 2020

1 August 2020

First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Covid-19 in Critically Ill Patients in the Seattle Region - Case Series

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

COVID-19 infection and rheumatoid arthritis: Faraway, so close!

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

On the use of corticosteroids for 2019-nCoV pneumonia

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Chimeric Antigen Receptor Therapy

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

In Vivo Infection Model of Severe Influenza A Virus

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Building blocks for institutional preparation of CTL019 delivery

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Chimeric antigen receptor T cells for sustained remissions in leukemia

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Current concepts in the diagnosis and management of cytokine release syndrome

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7194685

10.1016/J.BBMT.2020.04.008

23 February 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

0 references

0 references

Dimensions Publication ID

1126645363

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32298807%20AND%20SRC:MED&resulttype=core&format=json